# OnKure Therapeutics, Inc.: Form SCHEDULE 13D, filed Apr 7, 2026

- Company: [OnKure Therapeutics, Inc.](/companies/okur.md) (CIK 1637715)
- Form: SCHEDULE 13D
- Filed: 2026-04-07
- Accepted by EDGAR: Apr 7, 2026, 21:14 ET
- Period: not reported
- Accession: 0001193125-26-146025
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1637715/000119312526146025/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1637715/000119312526146025/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1637715/000119312526146025/xslSCHEDULE_13D_X02/primary_doc.xml

Filed Apr 7, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-146025. Last ingested by Listed: Nov 4, 2026, 17:06 ET. No prices; not investment advice.
